Clinical Trial Update: Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating BACOPP-21 for feasibility and efficacy in patients over 60 with intermediate or advanced Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• BACOPP-21

Snippet

Sponsor: University of Cologne | Conditions: Hodgkin´s Lymphoma | Phase 2 | Status: COMPLETED